GREGORY ALI: Open Payments
NPI 1871126813 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,362 in 212 payments from 47 companies in 2025. Trend: 2023 $2,357 · 2024 $1,101 · 2025 $5,362
Food & beverage: $5,307Education: $56
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $469 |
| EMD Serono, Inc. | 14 | $468 |
| Axsome Therapeutics, Inc. | 9 | $387 |
| TG Therapeutics, Inc. | 8 | $306 |
| Novartis Pharmaceuticals Corporation | 21 | $276 |
| UCB, Inc. | 10 | $269 |
| Lundbeck LLC | 6 | $215 |
| Lilly USA, LLC | 7 | $201 |
| Neurelis, Inc. | 5 | $199 |
| PFIZER INC. | 9 | $190 |
Products named: AUSTEDO XR, Symbravo, BRIUMVI, KESIMPTA, KISUNLA, VALTOCO, VYEPTI, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
